Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Zhang

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Frontiers in Immunology|November 17, 2022
Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised groupKangsan Kim, Madhusudhanan Narasimhan, Lenin Mahimainathan, et al.
Annals of Clinical and Translational Neurology|March 10, 2015
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trialsVissia Viglietta, David Miller, Amit Bar-Or, et al.
Neurology|February 15, 2015
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM studyDavid H Miller, Robert J Fox, J Theodore Phillips, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension studyRalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Science (New York, N.Y.)|March 17, 2007
Strong association of de novo copy number mutations with autismJonathan Sebat, B Lakshmi, Dheeraj Malhotra, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Frontiers in Immunology|November 17, 2022
Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised groupKangsan Kim, Madhusudhanan Narasimhan, Lenin Mahimainathan, et al.
Annals of Clinical and Translational Neurology|March 10, 2015
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trialsVissia Viglietta, David Miller, Amit Bar-Or, et al.
Neurology|February 15, 2015
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM studyDavid H Miller, Robert J Fox, J Theodore Phillips, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension studyRalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Science (New York, N.Y.)|March 17, 2007
Strong association of de novo copy number mutations with autismJonathan Sebat, B Lakshmi, Dheeraj Malhotra, et al.
Pageof 5